Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-29

Clinical Trial Update: Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effectiveness of low-dose theophylline for biomass-associated chronic obstructive pulmonary disease has completed. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Theophylline (Theophylline)

Snippet

Sponsor: University of Miami | Conditions: COPD, COPD Exacerbation | Phase 3 | Status: COMPLETED | Results posted: 2024-10-29